Revenue for Arexvy and Abrysvo fell sharply year over year in the fourth quarter due to narrower U.S. guidelines for their use.

LONDON - Shionogi & Co., Ltd. (TYO:4507) has reported positive outcomes from its Phase 2a human challenge trial for an investigational oral antiviral candidate targeting Respiratory Syncytial Virus ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug ...

The ranibizumab injection could be administered in a convenient schedule twice per year for the treatment of diabetic macular ...

Nirsevimab is protective against RSV infections and coinfections, which suggests there is no replacement of RSV with other viruses post-nirsevimab administration.

From today, February 3, pregnant women in Australia will be eligible for a free RSV vaccine under the National Immunisation ...

In this week's Tell Me Why episode, Dr. Feroza Dawood, Obstetrician and Gynecologist, explains to podcast host Maria Botros the dangers of respiratory syncytial virus (RSV) and the benefits of a ...

As we head into the peak of 2025 RSV season, parents are once again facing an uptick in cases, with health experts warning ...

Palivizumab injection is used to prevent serious lung infection in children and babies caused by respiratory syncytial virus ...

The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased risk for Guillain-Barré Syndrome (GBS) within 42 days of vaccination ...

The U.S. is seeing a "quad-demic" as cases of COVID-19, flu, RSV and norovirus spread at the same time. Experts said this is what you need to know. The so-called "quad-demic" includes flu ...